Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver-directed gene therapy

F A Nunes1, S E Raper

  • 1Division of Gastroenterology, University of Pennslyvania School of Medicine, Philadelphia 19104, USA.

The Medical Clinics of North America
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fitness costs on herbicide-resistant Digitaria insularis (L.) Fedde germination.

Brazilian journal of biology = Revista brasleira de biologia·2024
Same author

Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia.

Gene therapy·2001
Same author

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

Molecular therapy : the journal of the American Society of Gene Therapy·2001
Same author

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Journal of virology·2000
Same author

The fate of liver grafts declined for subjective reasons and transplanted out of a local organ procurement organization.

Transplantation·2000
Same author

Liver transplantation at the University of Pennsylvania and the Children's Hospital of Philadelphia.

Clinical transplants·2000
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Liver-directed gene therapy shows promise for treating liver diseases. Current gene delivery technology limitations hinder safe and stable therapeutic gene expression, but advancements may lead to effective clinical tools.

Area of Science:

  • Hepatology
  • Gene Therapy
  • Molecular Medicine

Background:

  • Liver-directed gene therapy is an emerging treatment for inherited and acquired liver diseases.
  • Clinical trials are ongoing for conditions including familial hypercholesterolemia (FH), ornithine transcarbamylase (OTC) deficiency, and liver cancer.

Purpose of the Study:

  • To highlight the potential of liver-directed gene therapy.
  • To identify current challenges in gene delivery for therapeutic applications.
  • To discuss future prospects for clinical gene therapy.

Main Methods:

  • Review of current clinical trials in liver-directed gene therapy.
  • Analysis of limitations in existing gene delivery technologies.
  • Discussion of ex vivo and in vivo gene therapy approaches.

Related Experiment Videos

Main Results:

  • Gene therapy for liver diseases is a promising therapeutic strategy.
  • Current gene delivery methods face challenges in achieving safe, stable, and therapeutic gene expression.
  • Ongoing research focuses on improving gene delivery efficiency and safety.

Conclusions:

  • Advancements in gene delivery technology are crucial for the clinical success of liver-directed gene therapy.
  • Improved delivery systems and refined therapeutic approaches (ex vivo and in vivo) are expected to yield effective clinical tools for liver disease treatment.